East and North Hertfordshire NHS Trust

Specialist MDT: East and North Hertfordshire NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services (updated 2019):

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy
    • Intensity-modulated radiotherapy
    • Low-dose rate brachytherapy
    • High-dose rate brachytherapy
    • Cryotherapy
    • Chemotherapy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Prostate cancer clinical nurse specialist (PCa CNS)
    • Advanced PCa CNS
    • Urology CNS
    • Oncology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 468 1098
Performance Status recorded 18% 45%
PSA completed 56% 70%
Gleason Score completed 86% 85%
TNM completed 76% 76%
Risk group assigned 93% 93%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 1043 49027
Percentage of men diagnosed with metastatic disease 14% 13%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 79 3055
Percentage of men with low-risk localised disease receiving radical treatment 7% 5%
No. of men diagnosed with locally advanced disease 324 19663
Percentage of men diagnosed with locally advanced disease receiving radical treatment 77% 71%
No. of men diagnosed with M1 (metastases) 146 6136
Percentage of men diagnosed with M1 (metastases) receiving docetaxel 39% 36%

Patient experience of care

Specialist MDT National
No. of men diagnosed 1st April 18 - 30th Sept 18 who had radical treatment (surgery or radiotherapy) and were sent a questionnaire 200 10750
Percentage of men who responded 80% 78%
No. of men who completed CNS question 159 8137
Percentage of men who were ‘given the name of a CNS’ 80% 87%
No. of men who rated their overall care on a scale of 1-10 150 7878
Percentage of men who rated their overall care as 8 or above 91% 91%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2018-2019) 236
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 15%
No. of men who received radical prostatectomy (2017) 147
Adjusted percentage of men experiencing at least one GU complication requiring a procedural/surgical intervention (%) 11%
No. of men who received radical radiotherapy (2017) 400
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 14%

Patient-reported outcomes

Treatment Centre
No. of men diagnosed 1st April 18 - 30th Sept 18 who received radical prostatectomy and were sent a questionnaire 97
Percentage of men who responded 74%
No. of men who completed sufficient information for a validated EPIC-26 urinary incontinence score to be determined 69
Adjusted EPIC-26 urinary incontinence score (0=worst to 100=best) 69
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined 72
Adjusted EPIC-26 sexual function score (0=worst to 100=best) 26
No. of men diagnosed 1st April 18 - 30th Sept 18 who received external beam radiotherapy and were sent a questionnaire 212
Percentage of men who responded 78%
No. of men who completed sufficient information for a validated EPIC-26 bowel function score to be determined 142
Adjusted EPIC-26 bowel function score (0=worst to 100=best) 81
No. of men who completed sufficient information for a validated EPIC-26 sexual function score to be determined 146
Adjusted EPIC-26 sexual function score (0=worst to 100=best) 22

Compare provider outcomes